Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER).
Herschorn S, Staskin D, Tu LM, Fialkov J, Walsh T, Gooch K, Schermer CR. Herschorn S, et al. Among authors: walsh t. Health Qual Life Outcomes. 2018 Apr 19;16(1):69. doi: 10.1186/s12955-018-0892-0. Health Qual Life Outcomes. 2018. PMID: 29673355 Free PMC article. Clinical Trial.
A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study).
Staskin D, Herschorn S, Fialkov J, Tu LM, Walsh T, Schermer CR. Staskin D, et al. Among authors: walsh t. Int Urogynecol J. 2018 Feb;29(2):273-283. doi: 10.1007/s00192-017-3377-5. Epub 2017 Jun 15. Int Urogynecol J. 2018. PMID: 28620791 Free PMC article. Clinical Trial.
Bacteriophage treatment is effective against carbapenem-resistant Klebsiella pneumoniae (KPC) in a neutropenic murine model of gastrointestinal translocation and renal infection.
Zagaliotis P, Michalik-Provasek J, Mavridou E, Naing E, Vizirianakis IS, Chatzidimitriou D, Gill JJ, Walsh TJ. Zagaliotis P, et al. Among authors: walsh tj. Antimicrob Agents Chemother. 2024 Dec 20:e0091924. doi: 10.1128/aac.00919-24. Online ahead of print. Antimicrob Agents Chemother. 2024. PMID: 39704532 Free article.
HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma.
Yamamoto N, Dobersch S, Loveless I, Samraj AN, Jang GH, Haraguchi M, Kang LI, Ruzinova MB, Vij KR, Mudd JL, Walsh T, Safyan RA, Chiorean EG, Hingorani SR, Bolton NM, Li L, Fields RC, DeNardo DG, Notta F, Crawford HC, Steele NG, Kugel S. Yamamoto N, et al. Among authors: walsh t. Clin Cancer Res. 2024 Dec 16. doi: 10.1158/1078-0432.CCR-24-2200. Online ahead of print. Clin Cancer Res. 2024. PMID: 39680021
Ensembl 2025.
Dyer SC, Austine-Orimoloye O, Azov AG, Barba M, Barnes I, Barrera-Enriquez VP, Becker A, Bennett R, Beracochea M, Berry A, Bhai J, Bhurji SK, Boddu S, Branco Lins PR, Brooks L, Ramaraju SB, Campbell LI, Martinez MC, Charkhchi M, Cortes LA, Davidson C, Denni S, Dodiya K, Donaldson S, El Houdaigui B, El Naboulsi T, Falola O, Fatima R, Genez T, Martinez JG, Gurbich T, Hardy M, Hollis Z, Hunt T, Kay M, Kaykala V, Lemos D, Lodha D, Mathlouthi N, Merino GA, Merritt R, Mirabueno LP, Mushtaq A, Hossain SN, Pérez-Silva JG, Perry M, Piližota I, Poppleton D, Prosovetskaia I, Raj S, Salam AIA, Saraf S, Saraiva-Agostinho N, Sinha S, Sipos B, Sitnik V, Steed E, Suner MM, Surapaneni L, Sutinen K, Tricomi FF, Tsang I, Urbina-Gómez D, Veidenberg A, Walsh TA, Willhoft NL, Allen J, Alvarez-Jarreta J, Chakiachvili M, Cheema J, da Rocha JB, De Silva NH, Giorgetti S, Haggerty L, Ilsley GR, Keatley J, Loveland JE, Moore B, Mudge JM, Naamati G, Tate J, Trevanion SJ, Winterbottom A, Flint B, Frankish A, Hunt SE, Finn RD, Freeberg MA, Harrison PW, Martin FJ, Yates AD. Dyer SC, et al. Among authors: walsh ta. Nucleic Acids Res. 2024 Dec 4:gkae1071. doi: 10.1093/nar/gkae1071. Online ahead of print. Nucleic Acids Res. 2024. PMID: 39656687
TP53 missense allele predisposing to high risk of breast cancer but not pediatric cancers.
Lolas-Hamameh S, Lieberman S, Sarahneh A, Walsh T, Lee MK, Gulsuner S, Rabie G, Beeri R, Aburayyan A, Mandell JB, Fridman H, Lazer-Derbeko G, Klopstock T, Freireich O, Lahad A, King MC, Levy-Lahad E, Kanaan MN. Lolas-Hamameh S, et al. Among authors: walsh t. J Natl Cancer Inst. 2024 Dec 14:djae334. doi: 10.1093/jnci/djae334. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 39673796
New developments for the Quest for Orthologs benchmark service.
Altenhoff A, Nevers Y, Tran V, Jyothi D, Martin M, Cosentino S, Majidian S, Marcet-Houben M, Fuentes-Palacios D, Persson E, Walsh T, Lecompte O, Gabaldón T, Kelly S, Hu Y, Iwasaki W, Capella-Gutierrez S, Dessimoz C, Thomas PD, Ebersberger I, Sonnhammer E. Altenhoff A, et al. Among authors: walsh t. NAR Genom Bioinform. 2024 Dec 11;6(4):lqae167. doi: 10.1093/nargab/lqae167. eCollection 2024 Dec. NAR Genom Bioinform. 2024. PMID: 39664814 Free PMC article.
Resolving the chromatin impact of mosaic variants with targeted Fiber-seq.
Bohaczuk SC, Amador ZJ, Li C, Mallory BJ, Swanson EG, Ranchalis J, Vollger MR, Munson KM, Walsh T, Hamm MO, Mao Y, Lieber A, Stergachis AB. Bohaczuk SC, et al. Among authors: walsh t. Genome Res. 2024 Dec 23;34(12):2269-2278. doi: 10.1101/gr.279747.124. Genome Res. 2024. PMID: 39653420
3,161 results